Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Preferred Stock Liabilities (2023)

Metagenomi (MGX) has disclosed Preferred Stock Liabilities for 1 consecutive years, with $350.8 million as the latest value for Q4 2023.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A to $350.8 million in Q4 2023 year-over-year; TTM through Dec 2023 was $350.8 million, a N/A change, with the full-year FY2023 number at $350.8 million, changed N/A from a year prior.
  • Preferred Stock Liabilities was $350.8 million for Q4 2023 at Metagenomi, roughly flat from $350.8 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $350.8 million in Q1 2023 to a low of $350.8 million in Q1 2023.